# US 2026/0083780 A1 · Complex for promoting cartilage differentiation comprising cartilage cell-free crush and stem cell and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083780 A1
- Document ID: US20260083780A1
- Status: Published application
- Kind: A1
- Application number: 19/225,491
- Filed: 2025-06-02
- Published: 2026-03-26
- Earliest claimed: 2016-07-04
- Applicants: Kangstem Biotech Co., Ltd.
- Inventors: Kyung Sun Kang; Seung Hee Lee; Jong Chan Ahn; Mi Jin Kim
- Web page: https://patentgrep.com/patent/US20260083780A1

## CPC

- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61K 35/51: Umbilical cord; Umbilical cord blood; Umbilical stem cells
- A61K 35/545: Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- A61K 38/1875: {Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor}
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/04: for non-specific disorders of the connective tissue
- C12N 5/0655: {Chondrocytes; Cartilage}
- C12N 5/0665: {Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood}
- C12N 2500/80: from animals
- C12N 2506/1369: from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a complex for promoting cartilage differentiation comprising stem cells or a culture thereof and a cartilage cell-free crush, a method for fabricating cartilage by using the complex, cartilage fabricated via the method, a pharmaceutical composition comprising the complex for preventing or treating arthropathy, a method for preventing or treating arthropathy using the composition, a composition for inducing cartilage cell differentiation comprising the prepared cartilage cells, and a method for fabricating cartilage using the prepared cartilage cells. The complex for promoting cartilage differentiation comprising the stem cells or the culture thereof and the cartilage cell-free crush provided in the present invention is not only differentiated into cartilage cells without side effects even in vivo, but also promotes differentiation of inherent stem cells in vivo into cartilage cells via a paracrine effect exhibited in the differentiated cartilage cells to effectively regenerate the damaged cartilage, and thus the complex may be widely used for treatment of arthropathy involving the cartilage damage.

## Claims

### Claim at position 1

-21. (canceled)

### Claim 22

A method for improving or treating arthropathy comprising administering by injection a complex for promoting cartilage differentiation comprising stem cells or a culture thereof and a cartilage cell-free crush or a pharmaceutical composition comprising the same to a subject in need thereof,
wherein the complex for promoting cartilage differentiation or the pharmaceutical composition is formulated for administration intraarticularly or into a joint cavity,
wherein the arthropathy involves degeneration or damage of cartilage,
wherein the stem cells or the culture thereof are co-administered with the cartilage cell-free crush,
wherein the cartilage cell-free crush is provided in an injection solution, and
wherein the stem cells or their cultures are differentiated into chondrocytes by the cartilage cell-free crush after administration.

### Claim 23 (depends on 22)

The method for improving or treating arthropathy of claim 22, wherein the arthropathy comprises polyarthrosis, coxarthrosis, gonarthrosis, osteoarthritis, or spondyloarthropathy.

### Claim 24 (depends on 22)

The method for improving or treating arthropathy of claim 22, wherein the stem cells comprise adult stem cells, pluripotent stem cells, induced pluripotent stem cells, umbilical cord blood mesenchymal stem cells, embryonic stem cells, placental stem cells, or autologous stem cells.

### Claim 25 (depends on 22)

The method for improving or treating arthropathy of claim 22, wherein the cartilage cell-free crush is selected from the group consisting of a crush obtained by mechanically crushing the cartilage matrix in which the cartilage cells are removed, repeating freezing/thawing of the cartilage matrix in which the cartilage cells are removed, or treating the cartilage matrix in which the cartilage cells are removed with ultrasonic waves; an enzyme hydrolysate obtained by treating the cartilage matrix in which the cartilage cells are removed with enzymes; a reaction product obtained by treating the cartilage matrix in which the cartilage cells are removed with an alkali or acidic reagent, or treating the cartilage matrix in which the cartilage cells are removed with a surfactant; and combinations thereof.

### Claim 26 (depends on 22)

The method for improving or treating arthropathy of claim 22, wherein the cartilage cell-free crush is porcine cartilage powder.

### Claim 27 (depends on 22)

The method for improving or treating arthropathy of claim 22, wherein the complex for promoting cartilage differentiation or the pharmaceutical composition further comprises an agent for promoting cartilage differentiation.

### Claim 28 (depends on 27)

The method for improving or treating arthropathy of claim 27, wherein the agent for promoting cartilage differentiation is bone morphogenetic protein 6 (BMP 6).

### Claim 29 (depends on 22)

The method for improving or treating arthropathy of claim 22, wherein the complex for promoting cartilage differentiation or the pharmaceutical composition is administered to a cartilage tissue, in the site of administration of which stem cells reside.

### Claim 30 (depends on 22)

The method for improving or treating arthropathy of claim 22 further comprising: administering an agent for promoting cartilage differentiation before, during, or after administering the complex for promoting cartilage differentiation or the pharmaceutical composition.

### Claim 31 (depends on 30)

The method for improving or treating arthropathy of claim 30, wherein the agent for promoting cartilage differentiation is bone morphogenetic protein 6 (BMP 6).
